Guidance for Managing Treatment-Resistant Schizophrenia
Different clinical and neurobiologic pathways may be involved in treatment-resistant schizophrenia as it is not a homogeneous subgroup within the schizophrenia spectrum.
Different clinical and neurobiologic pathways may be involved in treatment-resistant schizophrenia as it is not a homogeneous subgroup within the schizophrenia spectrum.
For patients with bipolar disorder and major depressive disorder, reduction in dose of antipsychotic medication could lead to an increased rate of hospitalization.
Augmentation therapy for treatment-resistant major depressive disorder includes multiple options with different strengths and limitations.
Children who are diagnosed on the autism spectrum are protected by their parents and community and are not properly actualized.
Updates made to the DSM-5 will clarify the diagnosis of bipolar disorder and related disorders.
Obsessive-compulsive disorder is a common disabling psychiatric condition.
Michael Thase, MD, discusses therapy options as well as side effect management for individuals with major depressive disorder.
The Psych Congress’s mission is to connect professionals representing all aspects of mental health treatment.
Scores for both anxiety and depression are associated with low BMD.
In children with autism, improvisational music therapy showed no significant difference in symptom outcome.